Comparison

beta Galactosidase (Biotin)*B1G1

Item no. 18-272-197535
Manufacturer GENWAY
Amount 1 mg
Category
Type Antibody
Applications WB, IP, IHC, ELISA
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-D18F0D
Similar products 18-272-197535
Available
Genway ID:
GWB-D18F0D
Isotype:
IgG
Immunogen:
Full length protein (E. coli)
Target:
beta Galactosidase
Localization:
Cytoplasmic
Conjugation:
BiotinConjugation
Note:
Label: Biotinamidocaproate N-Hydroxysuccinimide Ester (BAC). Biotin/Protein Ratio: 10-20 BAC molecules per Rabbit IgG molecule.
Concentration:
10 mg/ml
Purification Note:
From polyclonal serum Storage
Buffer:
0. 02 M Potassium Phosphate 0. 15 M Sodium Chloride pH 7. 2 10 mg/ml bovine serum albumin containing 0. 01% sodium azide
Application Note:
For ELISA 1:10 000-1:50 000. For WB: Use at 1:2 000-1:10 000. For IHC-Fr: Use at 1:1 000-1:5 000. User Optimized Not tested in other applications. Optimal dilutions/concentrations should be determined by the end user. Cellular
Localization:
Cytoplasmic This highly active polyclonal antibody is directed against the bacterial form of the enzyme and may be used to detect any beta-galactosidase expression by the lacZ gene. This reagent is specifically designed for screening and recovery of fusion proteins from expression systems with lacZ gene cloning sites.
Function:
Cleaves beta-linked terminal galactosyl residues from gangliosides glycoproteins and glycosaminoglycans.
Function:
Isoform 2 has no beta-galactosidase catalytic activity but plays functional roles in the formation of extracellular elastic fibers (elastogenesis) and in the development of connective tissue. Seems to be identical to the elastin-binding protein (EBP) a major component of the non-integrin cell surface receptor expressed on fibroblasts smooth muscle cells chondroblasts leukocytes and certain cancer cell types. In elastin producing cells associates with tropoelastin intracellularly and functions as a recycling molecular chaperone which facilitates the secretions of tropoelastin and its assembly into elastic fibers.
Catalytic Activity:
Hydrolysis of terminal non-reducing beta-D-galactose residues in beta-D-galactosides.
Subcellular Location:
Isoform 1: Lysosome.
Subcellular Location:
Isoform 2: Cytoplasm perinuclear region. Note=Localized to the perinuclear area of the cytoplasm but not to lysosomes.
Disease:
Defects in GLB1 are the cause of GM1-gangliosidosis type 1 (GM1G1) [MIM:230500]; also known as infantile GM1-gangliosidosis. GM1-gangliosidosis is an autosomal recessive lysosomal storage disease marked by the accumulation of GM1 gangliosides glycoproteins and keratan sulfate primarily in neurons of the central nervous system. GM1G1 is characterized by onset within the first three months of life central nervous system degeneration coarse facial features hepatosplenomegaly skeletal dysmorphology reminiscent of Hurler syndrome and rapidly progressive psychomotor deterioration. Urinary oligosaccharide levels are high. It leads to death usually between the first and second year of life.
Disease:
Defects in GLB1 are the cause of GM1-gangliosidosis type 2 (GM1G2) [MIM:230600]; also known as late infantile/juvenile GM1-gangliosidosis. GM1G2 is characterized by onset between ages 1 and 5. The main symptom is locomotor ataxia ultimately leading to a state of decerebration with epileptic seizures. Patients do not display the skeletal changes associated with the infantile form but they nonetheless excrete elevated amounts of beta-linked galactose-terminal oligosaccharides. Inheritance is autosomal recessive.
Disease:
Defects in GLB1 are the cause of GM1-gangliosidosis type 3 (GM1G3) [MIM:230650]; also known as adult or chronic GM1-gangliosidosis. GM1G3 is characterized by a variable phenotype. Patients show mild skeletal abnormalities dysarthria gait disturbance dystonia and visual impairment. Visceromegaly is absent. Intellectual deficit can initially be mild or absent but progresses over time. Inheritance is autosomal recessive.
Disease:
Defects in GLB1 are the cause of mucopolysaccharidosis type 4B (MPS4B) [MIM:253010]; also known as Morquio syndrome B. MPS4B is a form of mucopolysaccharidosis type 4 an autosomal recessive lysosomal storage disease characterized by intracellular accumulation of keratan sulfate and chondroitin-6-sulfate. Key clinical features include short stature skeletal dysplasia dental anomalies and corneal clouding. Intelligence is normal and there is no direct central nervous system involvement although the skeletal changes may result in neurologic complications. There is variable severity but patients with the severe phenotype usually do not survive past the second or third decade of life.
Similarity:
Belongs to the glycosyl hydrolase 35 family [view classification].

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close